CPD ADENINE CPDA 1
CPD ADENINE CPDA 1
Discontinued
DIN Number
00516775
Drug Class
Human
Market Date
Dec 31, 1981
Company
HC
fenwal labs, division of baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00516775
AIG Number0514462001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification20:12.04.92
Health Canada Classification
ACTIVE INGREDIENTS (5)
ADENINEActive
Strength: 28 MG / 100 ML
Monograph: ADENINE
CITRIC ACIDActive
Strength: 330 MG / 100 ML
Monograph: CITRIC ACID
DEXTROSEActive
Strength: 3.17 G / 100 ML
Monograph: DEXTROSE
SODIUM CITRATEActive
Strength: 2.63 G / 100 ML
Monograph: SODIUM CITRATE
SODIUM PHOSPHATE MONOBASICActive
Strength: 220 MG / 100 ML
Monograph: SODIUM PHOSPHATE MONOBASIC